Chemoproteomic profiling reveals histone H4 dopaminylation inhibiting cell growth
Zhang Yinfeng, Yang Yaqi, Wu Wenyan, Zhang Min, Rao Jianan, Song Wenting, Pan Yi, Shen Nan, Li Linxue, Min Taishan, Li Kai, Zhang Xiaoqing, Qiu Xin-Yue, Zhang Shu-Yu, Yang Wenjun, Zang Jianye, Liu Yu
Journal:Nature Chemical Biology
IF:15.8
DOI:10.1038/s41589-026-02225-x
PMID:42104010
Published:2026-05-08
research field:蛋白质组学分子生物学癌症生物学化学生物学表观遗传学
Abstract
Dopaminylation, the covalent attachment of dopamine to the side chain of glutamine in proteins, represents a newly characterized class of posttranslational modifications. Because of the limited identification of substrates, the functions and molecular mechanisms associated with dopaminylation remain largely uncharacterized. Using an alkyne-functionalized dopamine probe, we developed a method for selectively enriching dopaminylated proteins in whole-cell systems. This approach provided a comprehensive resource of 4,133 dopamine-enriched protein candidates and peptide-level analysis with acid-cleavable tags identified 1,181 putative dopaminylated proteins, including histone H4 dopaminylation at Q27 (H4Q27dop), which we further validated. Functionally, H4Q27dop acts as a transcriptional repressor in a neuroblastoma model, where it blocks CEBPD binding at the CCND1 promoter, leading to transcriptional downregulation of CCND1 and subsequent suppression of cell proliferation. Our findings provide both a valuable resource of dopaminylated substrate proteins and a distinct mechanistic insight into how dopamine regulates neuroblastoma cell growth. The alternative text for this image may have been generated using AI.
本文使用的Yeasen产品


